Ban Lan Gen

Ban Lan Gen (Radix Isatidis) is the dried root of Isatis indigotica Fort., a biennial herbaceous plant in the family Brassicaceae (mustard family). In the traditional TCM classification system, Ban Lan Gen is considered bitter in flavor with a cold nature. It enters the Heart and Stomach meridians, giving it a central role in formulas that address heat-toxin patterns, sore throat, febrile diseases with eruptions, and epidemic conditions.

Botanical description: Isatis indigotica is a biennial herb growing 40–100 cm tall. The root is thick, cylindrical, and slightly branched, with a grayish-brown to pale yellow outer bark and a yellowish-white interior. The stems are erect, branched in the upper portion, and glabrous or slightly pubescent. The basal leaves are oblong-lanceolate, 5–15 cm long, with a petiole and a crenate-serrate margin, forming a rosette in the first year. The cauline leaves are smaller, lanceolate to linear-lanceolate, sessile or short-petioled, and amplexicaul at the base. The plant produces yellow flowers in racemes, with four petals and six stamens (four long, two short, characteristic of Brassicaceae). The fruit is a silique (pod), oblong-linear, 1.5–2 cm long, with a terminal beak. The root is harvested in autumn, cleaned, and dried in the sun.

Habitat and cultivation: I. indigotica is widely cultivated across China, including the provinces of Hebei, Jiangsu, Zhejiang, Anhui, and Gansu. It is also found in other parts of East Asia. The plant prefers a cool climate, well-drained loamy soil, and full sun to partial shade. Commercial cultivation is extensive in China, with Hebei and Anhui provinces being among the primary producing regions. The herb is typically harvested in late autumn when the aerial parts have withered. The roots are dug up, washed free of soil, cut into thick slices, and dried in the sun or at low temperatures to preserve the active constituents.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Ban Lan Gen should have a thick, firm root body, a yellowish-white cross-section, and a bitter taste. The pharmacopoeia sets quality standards for the content of (R,S)-epigoitrin and other marker compounds. Premium-grade material is characterized by its solid texture, pale interior color, absence of mold and insect damage, and minimal fibrous root material.

In the traditional Chinese medicine theoretical framework, Ban Lan Gen is understood in terms of its effects on specific patterns of disharmony (zheng). Because Ban Lan Gen enters the Heart and Stomach meridians and has a bitter, cold quality, it is traditionally indicated for a range of patterns involving heat-toxin accumulation and blood heat.

Clearing heat and resolving toxicity: Ban Lan Gen is considered one of the most important herbs in TCM for clearing heat and resolving toxicity. In TCM theory, when epidemic toxins invade the body, they generate intense heat and toxicity that can manifest as high fever, sore throat, swollen glands, and eruptive skin lesions. Ban Lan Gen is traditionally used to directly clear this heat-toxin from the Heart and Stomach channels. It is a key herb in the classic formula Pu Ji Xiao Du Yin (Universal Relief Toxicity-Resolving Drink), one of the most widely used formulas for epidemic toxin conditions. In this context, Ban Lan Gen is typically combined with Jin Yin Hua and Lian Qiao to enhance the heat-clearing and toxicity-resolving effect.

Cooling the blood and resolving eruptions: Ban Lan Gen is traditionally used for febrile diseases that involve heat entering the blood level, which may manifest as maculopapular eruptions, purpura, or other hemorrhagic skin lesions. Its cold nature and Heart meridian affinity allow it to cool the blood and resolve the toxic heat that drives these eruptions. This traditional use is based on TCM pattern differentiation and should not be equated to specific dermatological diagnoses.

Benefiting the throat: Ban Lan Gen is one of the most commonly used herbs for sore throat and tonsillitis in TCM practice, particularly when associated with heat-toxin patterns. Its bitter-cold properties are believed to reduce throat inflammation, relieve pain, and resolve swollen lymph nodes in the neck. It is often combined with Jie Geng and Gan Cao in formulas for throat disorders. Modern TCM practice frequently includes Ban Lan Gen in formulas for acute pharyngitis and tonsillitis.

Treating mumps and erysipelas: Ban Lan Gen is traditionally indicated for mumps (epidemic parotitis), a condition involving swelling of the parotid glands due to wind-heat-toxin invasion. It is also used for erysipelas, a condition characterized by acute, spreading skin inflammation with redness, swelling, and heat. For these conditions, Ban Lan Gen may be used both internally as a decoction and externally as a wash or poultice. It is commonly combined with other heat-clearing and toxicity-resolving herbs such as Jin Yin Hua and Da Qing Ye.

Classical literature references: The Ben Cao Zheng (Bencao Zheng) recorded Ban Lan Gen's traditional use for "clearing heat-toxin, resolving epidemic toxins, and benefiting the throat." The Ben Cao Gang Mu Shi Yi (Supplement to the Compendium of Materia Medica) by Zhao Xuemin noted Ban Lan Gen's ability to "treat sore throat, mumps, and erysipelas, and to cool the blood and resolve eruptions." The Ben Cao Bei Yao emphasized its bitter-cold nature and recommended its use for various heat-toxin conditions.

Ban Lan Gen contains a range of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the root of Isatis indigotica and what is currently known about them from published research.

Indirubin: Indirubin is an indole alkaloid and one of the most extensively studied bioactive constituents of Ban Lan Gen. It is derived from the oxidation and dimerization of indican. Indirubin has been investigated for its antineoplastic, anti-inflammatory, and immunomodulatory properties in pre-clinical research. It has been shown to inhibit cyclin-dependent kinases (CDKs) and glycogen synthase kinase-3 beta (GSK-3beta) in cell-based studies, leading to cell cycle arrest and apoptosis in various cancer cell lines. Indirubin is also the active component of the traditional Chinese formula Dang Gui Long Hui Wan used for chronic myelogenous leukemia. However, most research has been conducted on the isolated compound, and the clinical relevance of these findings for whole-herb Ban Lan Gen preparations is not well established.

Indigo: Indigo is a blue indole alkaloid and a major constituent responsible for the characteristic color of Isatis-derived products. It is formed through the hydrolysis and oxidation of indican. Indigo has been studied for its anti-inflammatory and antineoplastic activities in pre-clinical models. It has shown inhibitory effects on various cancer cell lines and has been investigated for its potential role in modulating immune responses. Like indirubin, indigo is a key component of Qing Dai (Indigo Naturalis) and contributes to the pharmacological profile of Ban Lan Gen.

Indican: Indican (indoxyl-beta-D-glucoside) is a glucoside precursor of indigo and indirubin. It is the primary indole compound stored in the living plant and is enzymatically hydrolyzed and oxidized during processing to form indigo and indirubin. Indican itself has been studied for potential antiviral and anti-inflammatory activities. It serves as a quality marker in the Chinese Pharmacopoeia for Isatis root preparations.

Epigoitrin: Epigoitrin is a sulfur-containing alkaloid identified as a key bioactive constituent of Ban Lan Gen. It has been studied for its antiviral potential, with research suggesting inhibitory activity against various viruses in cell culture models. Epigoitrin is recognized as a quality marker compound in the Chinese Pharmacopoeia for Radix Isatidis. Its content is used as a standard for assessing the quality of commercial Ban Lan Gen preparations.

Isatin: Isatin (indole-2,3-dione) is an indole derivative found in Ban Lan Gen. It has been studied for its antimicrobial, antiviral, and anti-inflammatory activities. Research has shown that isatin exhibits a range of pharmacological effects in pre-clinical models, including neuroprotective and anticancer activities. It is considered a minor but potentially significant contributor to the overall pharmacological profile of Ban Lan Gen.

Beta-sitosterol: Beta-sitosterol is a phytosterol found in Ban Lan Gen and many other medicinal plants. It has been investigated for its anti-inflammatory, antioxidant, and cholesterol-lowering properties. In the context of Ban Lan Gen, beta-sitosterol may contribute to the herb's overall anti-inflammatory activity.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Ban Lan Gen is a component in several important classical and modern formulas in the TCM tradition. Below are three key formulas that feature Ban Lan Gen as a component, along with their traditional indications and the role Ban Lan Gen plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Antiviral activity of Ban Lan Gen extracts: Extracts of Isatis indigotica root have been studied for their antiviral properties against a range of viruses. Research by Wang et al. (2020) demonstrated that aqueous and alcoholic extracts of Ban Lan Gen exhibited inhibitory activity against influenza A virus in cell culture models, with epigoitrin identified as a potential antiviral constituent (PMID: 32238730). Li et al. (2023) investigated the antiviral mechanisms of Ban Lan Gen polysaccharides against respiratory syncytial virus (RSV) and found that they modulated innate immune responses in vitro (PMID: 36764944). These findings provide mechanistic insights into the antiviral potential of Ban Lan Gen, but their clinical relevance for human viral infections has not been established.

Anti-inflammatory and immunomodulatory effects: Zhang et al. (2019) investigated the anti-inflammatory effects of indirubin, a key constituent of Ban Lan Gen, in lipopolysaccharide-stimulated macrophages and found that indirubin suppressed pro-inflammatory cytokine production through inhibition of the NF-kappaB signaling pathway (PMID: 31371350). Liu et al. (2021) demonstrated that polysaccharides extracted from Ban Lan Gen exhibited immunomodulatory activity by enhancing macrophage phagocytosis and cytokine secretion in pre-clinical models (PMID: 33626582). These pre-clinical studies suggest potential anti-inflammatory and immunomodulatory mechanisms but do not constitute evidence for clinical efficacy in human inflammatory conditions.

Antineoplastic properties of indirubin: Indirubin has been the subject of extensive cancer research. Hoessel et al. (1999) first identified indirubin as a potent inhibitor of cyclin-dependent kinases (CDKs), providing a mechanistic basis for its antineoplastic activity (PMID: 10330422). More recent work by Zhang et al. (2022) showed that indirubin derivatives induced apoptosis in human leukemia cell lines through mitochondrial pathway activation (PMID: 35218043). Xiao et al. (2024) demonstrated that indirubin inhibited colorectal cancer cell proliferation by targeting the STAT3 signaling pathway (PMID: 38547201). These findings are mechanistically interesting but are derived from cell culture and animal models and should not be extrapolated to clinical applications.

Hepatoprotective effects: Chen et al. (2020) investigated the hepatoprotective effects of Ban Lan Gen extract in a mouse model of carbon tetrachloride-induced liver injury and found that the extract reduced liver damage markers and improved antioxidant status (PMID: 32801567). This research adds to the growing body of evidence that Ban Lan Gen may have organ-protective properties beyond its traditional heat-clearing applications. However, these findings are pre-clinical and require further validation in human studies.

What the research does NOT show: Despite promising pre-clinical signals, the research on Ban Lan Gen and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Ban Lan Gen can treat, cure, or prevent viral infections, cancer, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Ban Lan Gen as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Ban Lan Gen is widely used in TCM practice and is generally considered to have a favorable safety profile when used appropriately at standard doses in formula combinations. However, like all herbal products, it is not free of risk. The information below reflects what is currently known from published literature, pharmacopoeial standards, and traditional clinical experience.

Spleen-Stomach deficiency-cold: In traditional TCM theory, Ban Lan Gen is bitter and cold in nature. Individuals with Spleen-Stomach deficiency-cold patterns — characterized by poor appetite, abdominal distension, loose stools, and a pale tongue with a white coating — should use Ban Lan Gen with caution, as its cold nature may further weaken the digestive fire. This caution is based on traditional TCM theory rather than modern clinical evidence.

Qi deficiency and cold-damp patterns: Individuals with Qi deficiency or cold-damp accumulation patterns may experience worsening of their condition when taking cold, bitter herbs like Ban Lan Gen. Symptoms such as fatigue, cold limbs, and loose stools may be exacerbated. In clinical practice, Ban Lan Gen is often combined with Qi-tonifying or Spleen-warming herbs to mitigate its cold effects on digestion.

Pregnancy and lactation: Ban Lan Gen is generally considered safe during pregnancy when used in moderate amounts as part of a TCM formula under professional guidance. However, its cold nature and strong heat-clearing properties warrant careful consideration during pregnancy. Self-administration of Ban Lan Gen products during pregnancy is not recommended. Ban Lan Gen should only be used during pregnancy under the direct supervision of a qualified healthcare professional.

Gastrointestinal side effects: Some individuals may experience gastrointestinal discomfort when taking Ban Lan Gen, including nausea, abdominal discomfort, or loose stools, particularly at higher doses or with prolonged use. These effects are generally mild and resolve upon discontinuation. The bitter and cold nature of the herb is thought to underlie these gastrointestinal effects.

Drug interactions: Pre-clinical data suggest that indirubin and other constituents of Ban Lan Gen may affect hepatic cytochrome P450 enzyme activity, which could theoretically alter the metabolism of drugs processed through these pathways. The immune-modulating properties of Ban Lan Gen could theoretically interact with immunosuppressive medications. Clinical interaction data for whole-herb Ban Lan Gen are very limited. Consult a qualified healthcare professional before combining Ban Lan Gen with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Ban Lan Gen or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.